BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced that it has appointed Matthew J. Meyer as its Vice President of Corporate Development and Legal Affairs.
